Immunoassay for Neurological Biomarkers Market, By Product Type (Instruments, Reagents, and Services), By Disease, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV2060
|
Published Date
July 2026
|
Pages
368
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Immunoassay for Neurological Biomarkers Market size was valued at USD 1,090.3 Million in 2025, expanding to a CAGR of 9.1% from 2026 to 2033.
Immunoassays for neurological biomarkers are advanced analytical techniques that utilize highly specific antigen–antibody interactions to detect and quantify biomarkers associated with neurological disorders. These assays play a crucial role in the diagnosis, disease progression monitoring, prognosis, and evaluation of therapeutic responses for various neurological conditions. By providing valuable insights into disease mechanisms and patient status, immunoassays enable clinicians and researchers to improve disease understanding, enhance clinical decision-making, and support the development of targeted therapies. According to the World Health Organization (WHO), neurological disorders affect hundreds of millions of people worldwide and represent one of the leading causes of disability and disease burden globally.
Immunoassay for Neurological Biomarkers Market- Market Dynamics
Increasing Burden of Neurological Disorders and Technological Advancements in Biomarker Diagnostics Fuel Market Expansion
The global immunoassay for neurological biomarkers market is witnessing significant growth, driven by the increasing prevalence of neurological and neurodegenerative disorders worldwide. The rising incidence of conditions such as Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and various forms of dementia is creating a growing demand for advanced diagnostic solutions. Immunoassays play a crucial role in the early identification of disease-associated biomarkers, enabling detection before the onset of severe clinical symptoms. Furthermore, advancements in assay sensitivity, multiplex testing capabilities, and the development of blood-based biomarker detection methods are significantly contributing to market expansion. The increasing adoption of minimally invasive diagnostic approaches is also supporting market growth.
The market is further propelled by continuous advancements in immunoassay technologies and the growing adoption of precision medicine approaches in neurological care. Increased investments in neuroscience research, biomarker discovery and validation initiatives, and companion diagnostic development are fostering innovation across the industry. Key market trends include the commercialization of blood-based diagnostic tests for Alzheimer’s disease and the adoption of advanced multiplex immunoassay platforms capable of analyzing multiple biomarkers from a single patient sample. These technological advancements are enhancing diagnostic accuracy, streamlining clinical decision-making, reducing testing complexities, and enabling wider adoption of neurological biomarker testing across hospitals, diagnostic laboratories, and research institutions. Additionally, rising funding for neuroscience research and the development of novel biomarker-based diagnostic tools are further accelerating market growth. As neurological disorders become increasingly complex, sophisticated immunoassay platforms are gaining importance in disease classification, patient stratification, treatment monitoring, and personalized disease management.
Immunoassay for Neurological Biomarkers Market- Segmentation Analysis:
The Global Immunoassay for Neurological Biomarkers Market is segmented on the basis of Product Type, Disease, End User, and Region.
The market is segmented into four major disease categories: Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and others. Among these, Alzheimer’s disease holds a significant share of the immunoassay for neurological biomarkers market, primarily due to its high global prevalence and increasing demand for early and accurate diagnostic solutions. Additionally, rising healthcare expenditure, growing research initiatives, and continuous advancements in immunoassay technologies are driving the adoption of biomarker-based testing methods for Alzheimer’s disease. These factors are expected to further support the growth of the Alzheimer’s disease segment during the forecast period.According to the World Health Organization (WHO), more than 55 million people worldwide are living with dementia, with Alzheimer’s disease accounting for the majority of cases.
Immunoassay for Neurological Biomarkers Market- Geographical Insights
The Asia-Pacific region represents one of the fastest-growing markets for immunoassays used in neurological biomarker testing, driven by increasing healthcare expenditure, the rising burden of neurological disorders, and ongoing improvements in diagnostic and research infrastructure. Countries such as China, Japan, South Korea, and India are making significant investments in neuroscience research programs, expanding clinical diagnostic capabilities, and improving access to advanced biomarker testing technologies. According to the World Health Organization (WHO), neurological disorders contribute substantially to the global disease burden, with aging populations being a major factor increasing the incidence of neurodegenerative conditions. The rapidly growing elderly population in Asia-Pacific, increasing awareness regarding neurological diseases, and greater emphasis on early diagnosis and preventive healthcare are expected to further accelerate regional market growth.
North America remains a leading market for immunoassays in neurological biomarker testing, supported by its advanced healthcare infrastructure, strong research ecosystem, and early adoption of innovative diagnostic technologies. The region benefits from the presence of major biotechnology and diagnostic companies, substantial government and private-sector funding, and increasing demand for biomarker-based testing solutions for neurological conditions such as Alzheimer’s disease and Parkinson’s disease. According to government health agencies, millions of people in North America are affected by neurological disorders, creating a growing need for improved diagnostic and monitoring approaches. Furthermore, continued investments in precision medicine, neuroscience research, and the development of next-generation biomarker assays are expected to strengthen the region’s market position over the forecast period.
U.S. Immunoassay for Neurological Biomarkers Market- Key Insights
The United States represents a significant market for immunoassays used in neurological biomarker testing, supported by its advanced biotechnology sector, well-established neuroscience research ecosystem, and rapid adoption of innovative diagnostic technologies. The growing prevalence of neurological and neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and other related conditions, is increasing the demand for accurate, reliable, and minimally invasive biomarker-based diagnostic solutions. According to national health organizations, millions of individuals in the United States are affected by neurological disorders, creating a substantial need for improved early detection and disease monitoring approaches. Furthermore, healthcare providers and clinical researchers are increasingly incorporating biomarker testing into neurological care pathways to enable earlier diagnosis, enhance disease assessment, and support more personalized treatment strategies.
Immunoassay for Neurological Biomarkers Market- Competitive Landscape:
The immunoassay for neurological biomarkers market is highly competitive, with participation from leading diagnostics manufacturers, life sciences companies, and biotechnology firms that are focused on improving assay performance, accuracy, and clinical applications. Market players are actively investing in research and development activities to discover novel neurological biomarkers, enhance assay sensitivity, and develop advanced testing platforms with improved analytical capabilities. Additionally, strategic collaborations and partnerships between diagnostic companies, pharmaceutical firms, academic institutions, and research organizations are contributing to market expansion by accelerating innovation and supporting the development of next-generation biomarker testing solutions. These initiatives are enabling companies to strengthen their market presence, broaden their product portfolios, and enhance the clinical adoption of neurological biomarker assays.
Recent Developments:
- In January 2025, Roche expanded its neurological diagnostics portfolio by introducing advanced blood-based biomarker testing solutions designed to support earlier identification and improved diagnosis of neurological conditions.
- In June 2025, Abbott Laboratories enhanced its immunodiagnostics portfolio by advancing automated neurological biomarker testing capabilities, enabling improved laboratory efficiency and supporting more accurate diagnostic workflows.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET KEY PLAYERS
- Roche Diagnostics
- Siemens Healthineers
- Fujirebio
- Quanterix Corporation
- Revvity, Inc.
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Becton, Dickinson and Company (BD)
- Agilent Technologies, Inc.
- Bio-Techne Corporation
- QIAGEN
- Diasorin S.p.A.
- Beckman Coulter, Inc. (Danaher)
- Others
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020-2033
- Instruments
- Reagents
- Services
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY DISEASE- MARKET ANALYSIS, 2020-2033
- Alzheimer\'s Disease
- Parkinson\'s Disease
- Multiple Sclerosis
- Traumatic Brain Injury (TBI)
- Others
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY END USER- MARKET ANALYSIS, 2020-2033
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Others
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2020-2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Immunoassay for Neurological Biomarkers Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.2. Competitive Insights
3. Immunoassay for Neurological Biomarkers Key Market Trends
3.1. Immunoassay for Neurological Biomarkers Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Immunoassay for Neurological Biomarkers Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Immunoassay for Neurological Biomarkers Market Opportunities
3.4. Immunoassay for Neurological Biomarkers Market Future Trends
4. Immunoassay for Neurological Biomarkers Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Immunoassay for Neurological Biomarkers Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Immunoassay for Neurological Biomarkers Market Landscape
6.1. Immunoassay for Neurological Biomarkers Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Immunoassay for Neurological Biomarkers Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
7.1.2. Instruments
7.1.3. Reagents
7.1.4. Services
8. Immunoassay for Neurological Biomarkers Market – By Disease
8.1. Overview
8.1.1. Segment Share Analysis, By Disease, 2025 & 2033 (%)
8.1.2. Alzheimer\'s Disease
8.1.3. Parkinson\'s Disease
8.1.4. Multiple Sclerosis
8.1.5. Traumatic Brain Injury (TBI)
8.1.6. Others
9. Immunoassay for Neurological Biomarkers Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
9.1.2. Hospitals
9.1.3. Diagnostic Laboratories
9.1.4. Research Institutes
9.1.5. Others
10. Immunoassay for Neurological Biomarkers Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
10.2.1. Overview
10.2.2. Immunoassay for Neurological Biomarkers Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.5. North America Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Immunoassay for Neurological Biomarkers Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.16. Denmark
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.16.4. Denmark Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.17. Rest of Europe
10.3.17.1. Overview
10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.17.4. Rest of the Europe Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Immunoassay for Neurological Biomarkers Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.15. Taiwan
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.15.4. Taiwan Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.16. Vietnam
10.4.16.1. Overview
10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.16.4. Vietnam Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.17. Rest of APAC
10.4.17.1. Overview
10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.17.4. Rest of APAC Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Immunoassay for Neurological Biomarkers Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Immunoassay for Neurological Biomarkers Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.13. Iran
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.13.4. Iran Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.14. Qatar
10.6.14.1. Overview
10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.14.4. Qatar Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.15. Rest of MEA
10.6.15.1. Overview
10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.15.4. Rest of MEA Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- Immunoassay for Neurological Biomarkers Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Roche Diagnostics
11.2.2. Siemens Healthineers
11.2.3. Fujirebio
11.2.4. Quanterix Corporation
11.2.5. Revvity, Inc.
11.2.6. Abbott Laboratories
11.2.7. Bio-Rad Laboratories, Inc.
11.2.8. Thermo Fisher Scientific Inc.
11.2.9. Sysmex Corporation
11.2.10. Becton, Dickinson and Company (BD)
11.2.11. Agilent Technologies, Inc.
11.2.12. Bio-Techne Corporation
11.2.13. QIAGEN
11.2.14. Diasorin S.p.A.
11.2.15. Beckman Coulter, Inc. (Danaher)
11.2.16. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET KEY PLAYERS
- Roche Diagnostics
- Siemens Healthineers
- Fujirebio
- Quanterix Corporation
- Revvity, Inc.
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Becton, Dickinson and Company (BD)
- Agilent Technologies, Inc.
- Bio-Techne Corporation
- QIAGEN
- Diasorin S.p.A.
- Beckman Coulter, Inc. (Danaher)
- Others
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020-2033
- Instruments
- Reagents
- Services
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY DISEASE- MARKET ANALYSIS, 2020-2033
- Alzheimer\'s Disease
- Parkinson\'s Disease
- Multiple Sclerosis
- Traumatic Brain Injury (TBI)
- Others
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY END USER- MARKET ANALYSIS, 2020-2033
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Others
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2020-2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
